INSILICO MEDICINE

Serial Number 97552528
Registration 7377270
700

Registration Progress

Application Filed
Aug 17, 2022
Under Examination
Nov 7, 2023
Approved for Publication
Sep 12, 2023
Published for Opposition
Feb 20, 2024
Registered
May 7, 2024

Trademark Image

INSILICO MEDICINE

Basic Information

Serial Number
97552528
Registration Number
7377270
Filing Date
August 17, 2022
Registration Date
May 7, 2024
Published for Opposition
February 20, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 7, 2024
Registration
Registered
Classes
005

Rights Holder

Insilico Medicine IP Limited

99
Address
26th Floor
Three Exchange Square, 8 Connaught Place
Central 999077
HK

Ownership History

Insilico Medicine IP Limited

Original Applicant
99
Central HK

Insilico Medicine IP Limited

Owner at Publication
99
Central HK

Insilico Medicine IP Limited

Original Registrant
99
Central HK

Legal Representation

Attorney
Gregory J. Chinlund

USPTO Deadlines

Next Deadline
1735 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-05-07)
Due Date
May 07, 2030
Grace Period Ends
November 07, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

37 events
Date Code Type Description Documents
May 7, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 7, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 4, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 20, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 1, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 1, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 31, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 12, 2024 OTHE I CASE RETURNED TO EXAMINATION Loading...
Jan 12, 2024 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Dec 8, 2023 PCBG O PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Loading...
Dec 8, 2023 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Dec 7, 2023 APET A ASSIGNED TO PETITION STAFF Loading...
Nov 13, 2023 TPAD I TEAS PETITION TO AMEND BASIS RECEIVED Loading...
Nov 9, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Nov 9, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 9, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Nov 9, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 9, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 9, 2023 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Nov 9, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 7, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 12, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 12, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 23, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 8, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 26, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 26, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 26, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jul 26, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 13, 2023 ALIE A ASSIGNED TO LIE Loading...
Jun 13, 2023 CEPE I COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED Loading...
Jun 7, 2023 GEAP F EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Jun 7, 2023 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Jun 7, 2023 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Loading...
May 20, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 7, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 20, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Biological preparations for the treatment of cancer for medical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for treating fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders; diagnostic preparations for medical purposes; dietary supplements for human beings; Dietetic foods and beverages adapted for medical use; adjuvants for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Medicinal preparations for the mouth to be applied in the form of capsules; Pharmaceutical and biological preparations for the treatment of fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders and cancer for medical purposes

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MEDICINE"